4//SEC Filing
Deignan Charles A. 4
Accession 0001209191-23-002344
CIK 0001539029other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:28 PM ET
Size
5.6 KB
Accession
0001209191-23-002344
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-04+187,500→ 187,500 totalExercise: $1.48Exp: 2033-01-04→ Common Stock (187,500 underlying)
Footnotes (1)
- [F1]One-fourth of the shares underlying this option vest on January 4, 2024 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:28 PM ET
- Size
- 5.6 KB